Glioblastoma multiformenin (GBM) serebrospinal sıvı aracılığı ile omurgaya metastazı sık görülen bir durum değildir. Biz burada cerrahi ve kemoradyoterapi ile lokal tedavisinden sonra omurgaya metastaz yapan bir intrakranial GBM olgusunu sunduk. Hasta kranial GBM ile ilk gelişinden bir yıl sonra bel ağrısı ve alt ekstremitelerde güçsüzlükle başvurdu. Lomber magnetik rezonans görüntüleme incelemesinde L1'de intradural kitle izlendi. Yapılan eksizyonel biyopside GBM gösterildi. Anahtar Kelimeler: Glioblastoma multiforme; Metastaz; Omurga
Introduction
Glioblastoma Multiforme (GBM) is the most common primary malignant brain tumor. Extracranial metastasis of GBM is rare. It can metastasize to the spinal cord via cerebrospinal fluid (CSF) (1, 2) . The incidence of spinal metastasis of GBM through CSF is not known exactly. Our patient presented with symptomatic L1 radiculopathy after treatment of GBM without local recurrence.
Case Report
A 61 year-old-man presented with history of headache and dizziness for 5 months in March 2009. Cranial magnetic resonance imaging (MRI) showed right temporal, parahypocampal lesions of which the largest was 4.5 cm in diameter with peripheral edematous area ( Figure 1 ).
Right frontotemporal craniotomy and gross total excision were performed. Until April 2010, he had been followed without recurrence. In April 2010, he was admitted to the hospital with low back pain and right lower limb weakness. Spine MRI showed an extramedullary-intradural mass, measuring 38x18x13 mm in diameter (Figure 2 ). Medullary channel was filled fully with this mass and caudal fibers and conus medullaris were compressed. In May 2010, excisional biopsy was performed. Pathologic examination showed GBM, WHO grade IV (Figure 3) . Cranial MRI demonstrated no new or recurrent lesion. Focal RT and concurrent temozolamide were performed.
Discussion
We know that intracranial malign gliomas can metastasize via leptomeningeal spreading. Until 2010, totally 45 cases with intracranial GBM metastasized to spine were reported (1,2). Leptomeningeal spreading occurs in 15 to 25% of cases of supratentorial GBM, up to 60% for infratentorial GBM. In a study of 600 patients with GBM, only 2% had symptomatic CSF seeding (3) . The most common sites in spine are the lower thoracic, upper lumbar and lumbosacral regions. Intramedullary metastases are rare (3) (4) (5) . The mechanism of spread is leptomeningeal invasion of basement membrane structures, with subependymal growth and invasion of the choroid plexus, eventually leading to metastatic spread along CSF (6). Malignant tumor cells can penetrate from perivascular area to subarachnoid space. The most common clinical symptoms of leptomeningeal metastasis of GBM are radicular pain in limbs, low back, interscapular area, and neck (4) .
There are no spesific treatment modalities for leptomeningeal metastasis. Surgical decompression allows for confirmation of the diagnosis and may be helpful for pain control and palliation. Cytoreductive debulking of a large metastatic deposit may be an important adjunct to RT and chemotherapy (4) . Treatment modalities that have been designed to prevent leptomeningeal dissemination should be part of the primary management of high risk patients. One option is stereotactic biopsy with cranial RT and delayed open tumor resection. The prognosis of patient who has leptomeningeal metastasis is very poor. CSF tumor dissemination almost always has a fatal outcome (7). Median time from diagnosis of the primary GBM to diagnosis of CSF tumor dissemination ranges from 8 to 14 months, median overall survival ranges from 11 to 17 months, and the average time interval between diagnosis of leptomeningeal metastasis and death is 2 to 3 months (7-9). We present a case of GBM metastatic to the spinal cord with stable intracranial disease after adjuvant treatment.
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